Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000950170-25-085441

Options or other derivatives

  • Director acquired 78,893 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DOUGLAS RICHARD Director 2025-06-10 Grant or award · Stock Option (Right to Buy) +62,728 62,728 D
DOUGLAS RICHARD Director 2025-06-10 Grant or award · Stock Option (Right to Buy) +14,476 14,476 D
DOUGLAS RICHARD Director 2025-06-10 Grant or award · Stock Option (Right to Buy) +1,689 1,689 D
Loading xslF345X05/ownership.xml…